Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,764.40
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.07
(
0.61%
)
Bitcoin
70,271.00
(
0.53%
)
News Focus
News Focus

Replies to post #117265 on Biotech Values

Replies to #117265 on Biotech Values
icon url

DewDiligence

03/30/11 2:34 PM

#117301 RE: mcbio #117265

ACHN’s 4-week data for ACH-1625 are not especially noteworthy one way or the other, IMO. However, the results illustrate how much harder it’s going to be to interpret HCV data now that all patients are getting tested for IL-28B status.
icon url

DewDiligence

04/08/11 6:13 PM

#117950 RE: mcbio #117265

ACHN has bumped up the change-of-control benefits for executive officers:

http://sec.gov/Archives/edgar/data/1070336/000119312511092704/dex103.htm
http://sec.gov/Archives/edgar/data/1070336/000119312511092704/dex102.htm
http://sec.gov/Archives/edgar/data/1070336/000119312511092704/dex101.htm
http://sec.gov/Archives/edgar/data/1070336/000119312511092704/dex104.htm
http://sec.gov/Archives/edgar/data/1070336/000119312511092704/dex105.htm
http://sec.gov/Archives/edgar/data/1070336/000119312511092704/dex106.htm

FWIW